Development of Hepatocellular carcinoma (HCC) after Hepatitis C virus (HCV) infection is common cause of poor long-term survival. This study aimed to evaluate the effect of Vascular Endothelial growth factor (VEGF) genes polymorphism as a risk factor of Hepatocellular carcinoma (HCC) in chronic hepatitis C virus in Pakistani population. VEGF regulates angiogenesis so it is mainly involved in progression and development of solid tumor. The results showed that HCC patients had a higher frequency of the VEGF-634 GG genotype. In this study results revealed that VEGF Genotype GG is not associated with the risk of HCC in HCV infected patients in Punjab region of Pakistan.
. About ~2-3 % of world population has been infected whom around 85 % will lead to chronic infection with most dangerous outcomes i.e., liver fibrosis, cirrhosis and ultimately hepatocellular carcinoma (HCC) 
Statistical analysis
The continuous variables were expressed as mean ± SD. Differences in the frequency of polymorphisms were calculated the chisquared test. A p-value <0.05 was used to assess significance.
Results

General characteristics of the subjects
A total 288 patients were selected and they were categorized into 3 groups. Group I comprises of 98 healthy objects, Group II (96 patients of HCV infection and Group III (94 patients of HCC having HCV infection. Characteristics of these subjects are summarized in Table 1 No significant differences were observed in age and gender distribution between the cases and control (p value were 0.021 and 0.000 respectively). The smoking rates of the 2 groups were also nearby (p=0.987), However the drinking status is also nonsignificant (p=0.550).AST, Alpha fetoprotein and total bilirubin levels were considerably higher among the cases compared to controls (p > 0.05). However ALT. total protein and albumin were considerably lower among cases compared to controls (p < 0.05). In this study single nucleotide polymorphism was investigated for VEGF and its vulnerability to HCC in Pakistani population who already infected by HCV. The GG genotype was the most common genotype amongst all subjects relative to the CC and GC genotypes. When compared with the two previous studies of HCC, we observed significant differences in the genotypic and allelic frequencies of SNP rs2010963 (-634) amongst HCC patients. In the present study, the prevalence of the genotype CC was lower than that of GC or GG, and the G allele was more common than allele C [20, 21]. The two previous studies also reported the predominance of the GC genotype, but the difference in prevalence was less striking than the outcomes of this study. A previous study revealed that the genotype CC may predict an increased in survival of HCC patients after surgery and chemotherapy [20]. The prevalence of the CC genotype in this study was lower than the other genotypes (HCC 1 pts, HCV 3 pts, and healthy 2 pts). The prevalence of the VEGF SNP rs2010963 (-634) in HCV subjects has not been examined previously. Presently GG genotype and G allele were most common amongst all subjects. The frequency of the GC genotype and G allele in healthy subjects was significantly higher than in HCC and HCV subjects. The GG genotypes in HCV subjects are higher than healthy HCC which indicates that the increased frequency of the GG genotype reflects a decreased activity/expression of the VEGF protein. This research study involved only hospitalbased subjects who were recruited with the cross-sectional method, which cannot prove causality (cause-effect relationship) and cannot represent real situations in the general population. The role of other VEGF SNPs in VEGF expression in liver tissue and the levels of VEGF in the blood remain unclear. It will be important to evaluate polymorphisms in VEGFR not examined in this study. Biopsy is an invasive procedure that was often avoided by our subjects, and surgery (hepatoectomy) and transplantation were rarely performed in our hospitals thus, the researchers were unable to obtain a sample of hepatic tissue to measure the expression level of VEGF, VEGFR, and micro vascular density (MVD) in hepatic tissue. 
Conclusion
